LandedFees
APILog inStart a calculation
Lookups / Rulings

N330463

The tariff classification of Glipizide Tablets in dosage form, from Spain

HS3004909291
DateFeb 13, 2023
Ruling text
N330463 February 14, 2023 CLA-2-30:OT:RR:NC:N3 138 CATEGORY: Classification TARIFF NO.: 3004.90.9291 Carol Glenny Avila NorthStar Healthcare UC 3300 Cork Airport Business Park, Kinsale Road Cork T12 XN72 Ireland RE: The tariff classification of Glipizide Tablets in dosage form, from Spain Dear Ms. Glenny Avila: In your letter dated January 24, 2023, you requested a tariff classification ruling. Glipizide, imported in 5 mg and 10 mg tablets, is an anti-diabetic medication of the sulfonylurea class. It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. The applicable subheading for the Glipizide Tablets in dosage form will be 3004.90.9291, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided at https://hts.usitc.gov/current. This ruling is being issued under the provisions of Part 177 of the Customs and Border Protection Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, please contact National Import Specialist Judy Lee at judy.h.lee@cbp.dhs.gov. Sincerely, Steven A. Mack Director National Commodity Specialist Division
Related rulings on this HS code
Top 10 other CROSS rulings on HS 300490, newest first.
See all HS 300490 rulings →